EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Mild processing defect of porcine DeltaF508-CFTR suggests that DeltaF508 pigs may not develop cystic fibrosis disease



Mild processing defect of porcine DeltaF508-CFTR suggests that DeltaF508 pigs may not develop cystic fibrosis disease



Biochemical and Biophysical Research Communications 373(1): 113-118



Recent efforts have made significant progress in generating transgenic pigs with the DeltaF508-CFTR mutation to model the lung and pancreatic disease of human cystic fibrosis. However, species differences in the processing and function of human, pig and mouse DeltaF508-CFTR reported recently raise concerns about the phenotypic consequence of the gene-targeted pig model. The purpose of the present study was to characterize the DeltaF508 mutant of porcine CFTR to evaluate the severity of its processing defect. Biochemical and immunofluorescence analysis in transfected COS7 and FRT cells indicated that pig DeltaF508-CFTR efficiently targets to the plasma membrane and is present mainly as the mature glycosylated protein. Functional characterization in stably transfected FRT cells by fluorometric and electrophysiological assays supported efficient plasma membrane targeting of pig DeltaF508-CFTR. The mild cellular processing defect of pig DeltaF508-CFTR suggests that its gene-targeted pig model may not develop the lung and pancreatic phenotypes seen in CF patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 054387894

Download citation: RISBibTeXText

PMID: 18555011

DOI: 10.1016/j.bbrc.2008.06.009



Related references

Inhibition of protein kinase CK2 closes the CFTR Cl channel, but has no effect on the cystic fibrosis mutant deltaF508-CFTR. Cellular Physiology and Biochemistry 24(5-6): 347-360, 2010

ERp29 regulates DeltaF508 and wild-type cystic fibrosis transmembrane conductance regulator (CFTR) trafficking to the plasma membrane in cystic fibrosis (CF) and non-CF epithelial cells. Journal of Biological Chemistry 286(24): 21239-21253, 2011

Morphological changes in the vas deferens and expression of the cystic fibrosis transmembrane conductance regulator (CFTR) in control, deltaF508 and knock-out CFTR mice during postnatal life. Molecular Reproduction and Development 55(2): 125-135, 2000

Physiology of a cystic fibrosis DELTAF508-CFTR mouse model. Greger, R [Author], Jentsch, T J [Author] Nova Acta Leopoldina; Ion channels and disease : 145-146, 1997

Na+/H+ exchanger regulatory factor isoform 1 overexpression modulates cystic fibrosis transmembrane conductance regulator (CFTR) expression and activity in human airway 16HBE14o- cells and rescues DeltaF508 CFTR functional expression in cystic fibrosis cells. Journal of Biological Chemistry 280(49): 40925-40933, 2005

Global proteomic approach unmasks involvement of keratins 8 and 18 in the delivery of cystic fibrosis transmembrane conductance regulator (CFTR)/deltaF508-CFTR to the plasma membrane. Proteomics 4(12): 3833-3844, 2004

CFTR 9T allele of intron 8 associated with DELTAF508 mutation in patients with cystic fibrosis. Clinical Chemistry & Laboratory Medicine 37(SPEC SUPPL ): S151, June, 1999

DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis. Journal of Clinical Investigation 103(10): 1379-1389, 1999

DeltaF508-CFTR causes constitutive NF-kappaB activation through an ER-overload response in cystic fibrosis lungs. Biological Chemistry 383(2): 271-282, 2002

SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis. American Journal of Respiratory Cell and Molecular Biology 34(3): 355-363, 2005

A novel candidate gene to rescue misprocessing of DELTAF508 CFTR present in most patients with cystic fibrosis. Molecular Biology of the Cell 11(Supplement): 419a, 2000

Expression of DeltaF508 Cystic Fibrosis Transmembrane Regulator (CFTR) Decreases Membrane Sialylation. Open Respiratory Medicine Journal 3: 79-84, 2009

A novel identified protein, EMEP rescues misprocessing of DELTAF508 CFTR present in most patients with cystic fibrosis. Cell Structure & Function 26(5): 502, October, 2001